{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:00:02Z","timestamp":1747155602444,"version":"3.40.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","arthroplastytoday.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arthroplasty Today"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.artd.2024.101424","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T14:41:37Z","timestamp":1726670497000},"page":"101424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ninety-Day Outcomes in Primary Hypercoagulable Disease Patients Undergoing Total Joint Arthroplasty Vs Normal: A Matched Case-Control Series"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-6754","authenticated-orcid":false,"given":"Amir M.","family":"Boubekri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1496-759X","authenticated-orcid":false,"given":"Michael P.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8744-862X","authenticated-orcid":false,"given":"Nicolas","family":"Jozefowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold W.","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.artd.2024.101424_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1302\/0301-620X.98B5.34996","article-title":"Fatal pulmonary embolism following elective total hip arthroplasty","volume":"98-B","author":"Bayley","year":"2016","journal-title":"Bone Joint J"},{"key":"10.1016\/j.artd.2024.101424_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.arth.2016.10.020","article-title":"The incidence and economic burden of in-hospital venous thromboembolism in the United States","volume":"32","author":"Shahi","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.artd.2024.101424_bib3","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/j.1538-7836.2007.02571.x","article-title":"Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery","volume":"5","author":"Quinlan","year":"2007","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.artd.2024.101424_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.arth.2013.04.013","article-title":"Clinical outcomes of patients with non-fatal VTE after total knee arthroplasty","volume":"29","author":"Ast","year":"2014","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.artd.2024.101424_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13018-015-0285-6","article-title":"Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty","volume":"10","author":"Haighton","year":"2015","journal-title":"J\u00a0Orthop Surg Res"},{"key":"10.1016\/j.artd.2024.101424_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00402-014-2034-4","article-title":"High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline","volume":"134","author":"Borg","year":"2014","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.artd.2024.101424_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/8318595","article-title":"Multiple venous thromboembolism pharmacologic agents are associated with an increased risk for early postoperative complications following a total joint arthroplasty","volume":"2022","author":"Shaw","year":"2022","journal-title":"Advances in orthopedics"},{"key":"10.1016\/j.artd.2024.101424_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.thromres.2013.09.005","article-title":"Who are at risk for thromboembolism after arthroplasty? A systematic review and meta-analysis","volume":"132","author":"Zhou","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.artd.2024.101424_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/os.12901","article-title":"Patients undergoing primary total joint arthroplasty with primary hypercoagulable states","volume":"13","author":"Pan","year":"2021","journal-title":"Orthop Surg"},{"key":"10.1016\/j.artd.2024.101424_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/17474086.2019.1583555","article-title":"Thrombophilia, risk factors and prevention","volume":"12","author":"Campello","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.artd.2024.101424_bib11","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.161.20.2433","article-title":"Hypercoagulability syndromes","volume":"161","author":"Thomas","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.artd.2024.101424_bib12","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.arth.2019.10.050","article-title":"Does polycythemia vera increase risk of postoperative complications following primary total joint arthroplasty? A retrospective matched control cohort study of 6932 polycythemia vera patients","volume":"35","author":"Labaran","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.artd.2024.101424_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0037-1614410","article-title":"APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee \u2013 a prospective study","volume":"81","author":"Lindahl","year":"1999","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.artd.2024.101424_bib18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/medicina56090416","article-title":"An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020","volume":"56","author":"Santana","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.artd.2024.101424_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2141.2005.05419.x","article-title":"A\u00a0single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty","volume":"129","author":"Joseph","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.artd.2024.101424_bib15","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.artd.2024.101424_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.5435\/00124635-201112000-00008","article-title":"AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"19","author":"Mont","year":"2011","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.artd.2024.101424_bib17","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.artd.2024.101424_bib19","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.arth.2022.07.006","article-title":"Low dose aspirin for venous thromboembolism prophylaxis is associated with lower rates of periprosthetic joint infection after total joint arthroplasty","volume":"37","author":"Najafi","year":"2022","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.artd.2024.101424_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/os.12926","article-title":"Risk-stratified venous thromboembolism prophylaxis after total joint arthroplasty: low molecular weight heparins and sequential aspirin vs aggressive chemoprophylaxis","volume":"13","author":"Peng","year":"2021","journal-title":"Orthop Surg"},{"key":"10.1016\/j.artd.2024.101424_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis\u00a0after total hip and knee replacement","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.artd.2024.101424_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11999-010-1514-2","article-title":"Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study","volume":"469","author":"Bedair","year":"2011","journal-title":"Clin Orthop Relat Res"}],"container-title":["Arthroplasty Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344124001092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352344124001092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T23:23:52Z","timestamp":1729639432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352344124001092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":22,"alternative-id":["S2352344124001092"],"URL":"https:\/\/doi.org\/10.1016\/j.artd.2024.101424","relation":{},"ISSN":["2352-3441"],"issn-type":[{"type":"print","value":"2352-3441"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ninety-Day Outcomes in Primary Hypercoagulable Disease Patients Undergoing Total Joint Arthroplasty Vs Normal: A Matched Case-Control Series","name":"articletitle","label":"Article Title"},{"value":"Arthroplasty Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.artd.2024.101424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons.","name":"copyright","label":"Copyright"}],"article-number":"101424"}}